Related Experiment Videos
Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP
William R Gower1, Brian A Vesely, Abdel A Alli
1Department of Internal Medicine, University of South Florida Cardiac Hormone Center and James A. Haley Veterans Medical Center, Tampa, 33612, USA.
International Journal of Gastrointestinal Cancer
|May 2, 2006
Summary
Four peptide hormones significantly reduce colon cancer cells by up to 97% within 24 hours. These anticancer effects are mediated by cyclic guanosine monophosphate (cGMP).
Area of Science:
- Oncology
- Molecular Biology
- Endocrinology
Background:
- Colon cancer causes significant mortality, with limited treatment options.
- Natriuretic peptides demonstrate anticancer effects in other adenocarcinoma types.
Purpose of the Study:
- To investigate the anticancer effects of specific peptide hormones on colon adenocarcinoma cells.
- To determine if cyclic guanosine monophosphate (cGMP) mediates these anticancer effects.
Main Methods:
- Human colon adenocarcinoma cells were treated with four peptide hormones.
- Cell viability, proliferation, and DNA synthesis were assessed.
- The role of cGMP was evaluated using a cGMP antibody.
- Western blotting identified natriuretic peptide receptors (NPRs).
Main Results:
- A 89-97% decrease in colon cancer cells was observed within 24 hours.
- Concentration-dependent reduction in cell number and DNA synthesis (65-83%) occurred.
- cGMP mediated 75-97% of the observed anticancer and DNA synthesis effects.
- Natriuretic peptide receptors A and C were identified in colon cancer cells.
Conclusions:
- Four peptide hormones effectively eliminate a high percentage of colon cancer cells.
- The anticancer mechanisms are specifically mediated by cyclic guanosine monophosphate (cGMP).
- Natriuretic peptide receptors are present in colon adenocarcinoma cells, suggesting a potential therapeutic target.